Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial

N. Bahlis; A. Corso; L. -O. Mügge; Z. -X. Shen; P. Desjardins; A. M. Stoppa; O. Decaux; T. De Revel; M. Granell; G. Marit; H. Nahi; H. Demuynck; S. -Y. Huang; S. Basu; A. Ervin-Haynes; N. Leupin; J. Marek; G. Chen; T Facon

doi:10.1016/j.clml.2015.07.196

Conference Papers Year : 2015

Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial

, , , , , , (1, 2) , , , (3) , , , , , , , , ,

1
2
3

N. Bahlis

Function : Author

A. Corso

Function : Author

L. -O. Mügge

Function : Author

Z. -X. Shen

Function : Author

P. Desjardins

Function : Author

A. M. Stoppa

Function : Author

O. Decaux

Function : Author

Institut de Génétique et Développement de Rennes

CHU Pontchaillou [Rennes]

T. De Revel

Function : Author

M. Granell

Function : Author

G. Marit

Function : Author

Service des maladies du sang

H. Nahi

Function : Author

H. Demuynck

Function : Author

S. -Y. Huang

Function : Author

S. Basu

Function : Author

A. Ervin-Haynes

Function : Author

N. Leupin

Function : Author

J. Marek

Function : Author

G. Chen

Function : Author

T Facon

Function : Author

Abstract

no abstract

Domains

Life Sciences [q-bio]

Laurent Jonchère : Connect in order to contact the contributor

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01228160

Submitted on : Thursday, November 12, 2015-5:33:10 PM

Last modification on : Friday, March 24, 2023-2:53:01 PM

Dates and versions

hal-01228160 , version 1 (12-11-2015)

Identifiers

HAL Id : hal-01228160 , version 1
DOI : 10.1016/j.clml.2015.07.196

Cite

N. Bahlis, A. Corso, L. -O. Mügge, Z. -X. Shen, P. Desjardins, et al.. Impact of Response in Patients (Pts) With Stem Cell Transplant (SCT)-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Treated With Continuous Lenalidomide + Low-Dose Dexamethasone (Rd) in the FIRST Trial. 15th International Myeloma Workshop, Sep 2015, Rome, Italy. pp.e56, ⟨10.1016/j.clml.2015.07.196⟩. ⟨hal-01228160⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

UNIV-RENNES1 CNRS IGDR UR1-UFR-SVE UNIV-RENNES UR1-BIO-SA

34 View

0 Download